ATE173166T1 - Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien - Google Patents

Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien

Info

Publication number
ATE173166T1
ATE173166T1 AT93918846T AT93918846T ATE173166T1 AT E173166 T1 ATE173166 T1 AT E173166T1 AT 93918846 T AT93918846 T AT 93918846T AT 93918846 T AT93918846 T AT 93918846T AT E173166 T1 ATE173166 T1 AT E173166T1
Authority
AT
Austria
Prior art keywords
pathogenic bacteria
vaccine strains
mutation
new bacterial
bacterial vaccines
Prior art date
Application number
AT93918846T
Other languages
English (en)
Inventor
Brenda J Allan
Andrew A Potter
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Application granted granted Critical
Publication of ATE173166T1 publication Critical patent/ATE173166T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93918846T 1992-09-04 1993-09-03 Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien ATE173166T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93949692A 1992-09-04 1992-09-04
US11568393A 1993-09-03 1993-09-03

Publications (1)

Publication Number Publication Date
ATE173166T1 true ATE173166T1 (de) 1998-11-15

Family

ID=26813454

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93918846T ATE173166T1 (de) 1992-09-04 1993-09-03 Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien

Country Status (7)

Country Link
US (1) US5747309A (de)
EP (1) EP0659086B1 (de)
AT (1) ATE173166T1 (de)
AU (1) AU683221B2 (de)
CA (1) CA2143299A1 (de)
DE (1) DE69322092T2 (de)
WO (1) WO1994005326A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316005B1 (en) * 1994-04-11 2001-11-13 Solvay Animal Health, Inc. Borrelia burgdorferi bacterin
US6010705A (en) * 1997-04-11 2000-01-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Attenuated, invasive vaccines against fish pathogens
WO1998046725A2 (en) * 1997-04-11 1998-10-22 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Attenuated, invasive vaccines against fish pathogens
GB9711964D0 (en) * 1997-06-09 1997-08-06 Medical Res Council Live attenuated vaccines
US6019981A (en) * 1998-03-06 2000-02-01 The United States Of America As Represented By The Secretary Of Agriculture Modified live Edwardsiella ictaluri against enteric septicemia in channel catfish
US6153202A (en) * 1998-03-06 2000-11-28 The United States Of America As Represented By The Secretary Of Agriculture In ovo methods for utilizing live Edwardsiella ictaluri against enteric septicemia in channel catfish
US20020081317A1 (en) * 1999-02-02 2002-06-27 Mahan Michael J. Bacteria with altered DNA adenine methylase (DAM) activity and heterologous epitope
EP1069133A1 (de) 1999-07-13 2001-01-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Neisseria meningitidis Zusammensetzungen und ihre Verwendungen als anti-infektionsmitteln
WO2002053181A1 (en) * 2001-01-04 2002-07-11 University Of Saskatchewan Enterohemorragic escherichia coli vaccine
US7763451B2 (en) * 2001-11-09 2010-07-27 The United States Of America As Represented By The Department Of Health And Human Services Methods for preparing Bacillus anthracis protective antigen for use in vaccines
WO2003096812A1 (en) * 2002-04-15 2003-11-27 Washington University Regulated attenuation of live vaccines to enhance cross protective immunogenicity
US7334538B1 (en) * 2004-07-27 2008-02-26 Aquascience Research Group, Inc. Topical medicants for aquatic animals
GB0511203D0 (en) * 2005-06-02 2005-07-06 Univ Birmingham Vaccines
US20110129438A1 (en) * 2006-06-28 2011-06-02 James Robert Swartz Immunogenic protein constructs
PL2066339T3 (pl) * 2006-09-18 2015-02-27 Univ Arkansas Kompozycje i sposoby zwiększania odpowiedzi immunologicznych
JP2011502165A (ja) * 2007-10-30 2011-01-20 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー 鞭毛細菌に対する免疫応答を強化する組成物および方法
AU2008318357B2 (en) 2007-11-01 2015-01-22 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria
WO2011091255A1 (en) 2010-01-21 2011-07-28 The Board Of Trustees Of The University Of Arkansas Vaccine vectors and methods of enhancing immune responses
MX377650B (es) 2010-06-09 2025-03-11 Univ Arkansas Vacuna y métodos para reducir una infección por campylobacter.
US9200251B1 (en) 2011-03-31 2015-12-01 David Gordon Bermudes Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith
AR094791A1 (es) 2013-02-14 2015-08-26 Univ Arkansas Composiciones y métodos para mejorar las respuestas inmunes ante una infección por eimeria o para limitar una infección por eimeria
MX376350B (es) 2013-03-15 2025-03-07 Univ Arkansas Vectores para vacuna y uso de los mismos para aumentar la respuesta inmune contra patógenos entericos.
EP3452069A4 (de) 2016-05-03 2020-02-12 The Board of Trustees of the University of Arkansas Hefeimpfstoffvektor mit immunstimulierenden und antigenen polypeptiden und verfahren zur verwendung davon

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
US4190495A (en) * 1976-09-27 1980-02-26 Research Corporation Modified microorganisms and method of preparing and using same
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
US5210035A (en) * 1980-05-19 1993-05-11 Board Of Trustees Of Leland Stanford Jr. University Non-reventing live vaccines
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
FR2644346B1 (fr) * 1989-03-20 1994-05-13 Rhone Merieux Vaccins contre les bacteries septicemiques, preparations d'antigenes de bacteries septicemiques, nouvelles bacteries et vecteurs pour la preparation de ces antigenes ou vaccins
WO1991006317A1 (en) * 1989-11-03 1991-05-16 Washington University Cross-protective salmonella vaccines
US5213972A (en) * 1989-12-08 1993-05-25 Chemgen Corporation Fermentation process for the production of pyrimidine deoxyribonucleosides
GB9007194D0 (en) * 1990-03-30 1990-05-30 Wellcome Found Live vaccines
WO1992011361A1 (en) * 1990-12-18 1992-07-09 The General Hospital Corporation Improved vaccines
WO1992012732A1 (en) * 1991-01-29 1992-08-06 Regents Of The University Of Minnesota Live vaccine against colibacillosis

Also Published As

Publication number Publication date
DE69322092T2 (de) 1999-07-15
CA2143299A1 (en) 1994-03-17
EP0659086B1 (de) 1998-11-11
US5747309A (en) 1998-05-05
EP0659086A1 (de) 1995-06-28
AU4939193A (en) 1994-03-29
DE69322092D1 (de) 1998-12-17
AU683221B2 (en) 1997-11-06
WO1994005326A1 (en) 1994-03-17

Similar Documents

Publication Publication Date Title
ATE173166T1 (de) Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
WO1998056901A3 (en) Live attenuated vaccines
ATE85622T1 (de) Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus.
DE69806408D1 (de) Rekombinante impfstoffe die immunogene attenuierte rpos-positiv phentotyp bakterien enthalten
DK251890A (da) Polypeptid og dets anvendelse samt ekspressionssystem til dets eksprimering
UA40571C2 (uk) Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
IL147737A0 (en) Herbicidal compositions comprising post-emergence herbicides for soil application
HU0005010D0 (de)
BR0009663A (pt) Composições de vacinas antibacterianas
NO20004781D0 (no) Svekkede bakterier anvendelige i vaksiner
DE69133219D1 (de) Avirulente salmonella mikroben mit einer mutation in dem cdt gen und ihre verwendung
DK1666057T3 (da) Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
PT600396E (pt) Vacinas contra protozoarios intestinais
YU49995A (sh) Polinukleotidna vakcina za virus herpesa
FI944557A0 (fi) Mikro-organismi kasvitautien biologiseen torjuntaan
HU0002228D0 (en) Line attenuated bacteria for use in a vaccine
WO2000045840A8 (en) Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
DE3361138D1 (en) Ozone inactivated organisms as vaccines
FR2809960B1 (fr) Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante
AU1853995A (en) Vaccine compositions
DE69826712D1 (de) Impfstoffe die abgeschwächte bakterien enthalten
Abbott et al. Evaluation of a new selective agar, thiosulfate-chloride-iodide(TCI), for the growth of pathogenic Vibrio species
TH14768A (th) สายพันธุ์กลายชนิดของสารกรรมพันธุ์ที่ขาดแหว่งไปนำมาใช้เป็นวัคซีนอหิวาต์
AU2010201539B2 (en) Anti-bacterial vaccine compositions

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties